Initial experience with the subcutaneous implantable cardioverter‐defibrillator in a single Japanese center

• DOI: 10.1016/j.joa.2017.02.004
• Publication Date: 2017-03-31T08:03:18Z
• Authors: Nobuhiro Nishii; Motomi Tachibana; Yoshimasa Morimoto; Satoshi Kawada; Akihito Miyoshi; Hiroyasu Sugiyama; Koji Nakagawa; Atsuyuki Watanabe; Kazufumi Nakamura; Hiroshi Morita; Hiroshi Ito
• Keywords: Single Center

Abstract Background The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) is recognized as a viable alternative to the transvenous ICD. safety and efficacy of this device has been demonstrated in Western countries, but studies with S‐ICD implantation Japanese patients have not reported. Methods results Twelve received an implant our institute between February September 2016. All S‐ICDs were successfully implanted without complications. One appropriate one inappropriate therapy was identified. Conclusions appears provide ICD for some patients. However, we should perform careful follow‐up eliminate therapy.